knowledge -WSS

knowledge

author：comprehensive 2025-10-02 19:38:35 - browse：76611

Adam's take main illustration — Molly Ferguson/STAT

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

Do you have a biotech-related question you want me to answer in the newsletter? Send me an email at [email protected].

This week: A preview of Intra-Cellular Therapies’ Phase 3 study in major depressive disorder, and a couple of liver-disease physician perspectives on Rezdiffra, the newly approved treatment for MASH from Madrigal Pharmaceuticals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： 'A game

WSS

Eli Lilly CEO gives to Mike Pence presidential super PAC

NIH chief: government has fallen behind pharma on clinical trials

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Cancer diagnosis changes perspective doctor, former hospital CEO

Healthy food access boosts outcomes in two studies

Readout Newsletter: Zepbound, Valneva's vaccine, and more

focus

knowledge

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Midwives could help bridge maternal health disparities in the U.S.

Heart attack and stroke risk calculators need revising

Medicare’s new pay boost for primary care is angering specialists

Alkermes shareholders re

Assistant physicians can help address the primary care shortage

State Dept. review finds Biden bears some blame for Afghanistan failures

First transplant of an entire human eye performed

United colonoscopy coverage change 'may cost lives,' doctors say

Experimental asthma app from Apple and Anthem shows promise

Wikipedia

PBMs drew scrutiny in House hearing — and so did pharma

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

FDA reorg will put new emphasis on investigations, sources say

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Neurocrine congenital adrenal hyperplasia trial succeeds

'A game

leisure time

Wikipedia

Wikipedia

explore